Everything below concerns Peptidase stability. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
Regulatory treatment varies by jurisdiction. In Russia the compound is a registered prescription product, while in the European Union and the United States it is generally handled as a research chemical without a marketing authorization. Suppliers therefore operate outside pharmaceutical oversight, and buyers rely on supplier documentation for purity and identity claims. Chain of custody and third-party testing are the main verification tools. Analysts note that the absence of a pharmacopoeial monograph for research-grade material limits standardization across vendors.
Purity assessment relies mainly on reverse-phase high-performance liquid chromatography with ultraviolet detection. Because the peptide lacks a strong chromophore, detection often uses backbone absorbance near 214 nm. Identity is confirmed by mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, comparing the measured mass against the expected value. Amino acid analysis can verify composition after acid hydrolysis. Diastereomer content and residual counterions are reported less often, although both can influence biological assays.
Pharmacokinetic data are limited. Like most short peptides, Selank is vulnerable to plasma and tissue peptidases, and its measured half-life in circulation is short, on a minutes scale. The Pro-Gly-Pro tail slows this degradation but does not eliminate it. Intranasal administration is the route described in most reports, with absorption through the nasal mucosa and a hypothesized path into the central nervous system that avoids the blood-brain barrier. Direct measurements of human brain exposure are unavailable, so distribution claims rest on inference from animal work.
Clinical evidence comes mainly from small studies conducted in Russia, several of which were open-label or lacked robust blinding. Reported outcomes include lower anxiety scores, changes in attention measures, and effects on asthenic states following illness. Sample sizes are typically in the tens of participants, and independent replication outside the region is scarce. Reviews published in English generally note the limited methodological quality of the underlying trials. Whether the compound produces clinically meaningful effects under rigorous conditions remains unresolved.
Proposed mechanisms center on modulation of the GABA system, but no single molecular target has been confirmed. Rodent studies report changes in GABA-A receptor expression and in the turnover of serotonin, dopamine, and norepinephrine in several brain regions. Increases in brain-derived neurotrophic factor and its receptor have also been described after repeated administration. These findings come largely from animal models, and the degree to which they describe human neurochemistry remains an open question. The mechanism is best characterized as multi-system and not fully resolved.
| Property | Value | Notes |
|---|---|---|
| Typical purity report | 95% or higher by HPLC | Area percentage at 214 nm |
| Identity confirmation | Mass spectrometry | Electrospray or MALDI |
| Powder storage | -20 C, desiccated | Protect from light |
| Solution storage | 2-8 C short term | Freeze aliquots for longer |
| Quality document | Certificate of analysis | States method and value |
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, frequently abbreviated as TKPRPGP. It was designed as a structural analogue of tuftsin, a naturally occurring tetrapeptide released by enzymatic cleavage of the immunoglobulin heavy chain. The two additional proline residues at the C-terminal end extend the parent chain and change how the molecule behaves in solution. The free peptide has a calculated molecular mass of approximately 751.9 g/mol and is generally supplied as a lyophilised white to off-white powder.
Development work on the compound began in the 1980s and 1990s at the Institute of Molecular Genetics in Moscow, within the same research programme that produced the peptide Semax. Early investigators sought a tuftsin derivative with improved resistance to enzymatic breakdown and with activity in the central nervous system after peripheral administration. Most of the primary literature from this period was published in Russian, a factor that still shapes how easily the findings can be checked by outside groups.
Reported activity for Selank centers on anxiolytic and nootropic effects. Russian clinical reports describe use in anxiety and in cognitive or attention-related complaints. Most of this evidence comes from studies conducted by the same research groups that developed the peptide. Independent replication in other countries remains limited, and no major Western regulatory agency has approved the compound for any indication. The gap between local reports and external verification is a recurring point in discussions of the peptide.
Tuftsin, the parent structure, is a naturally occurring immunomodulatory tetrapeptide released from the Fc region of immunoglobulin G by spleen enzymes. Selank extends this four-residue sequence with three additional amino acids. The stated rationale is that the added tail slows enzymatic breakdown and may influence receptor interactions. How the full heptapeptide behaves at the molecular level is not firmly established, and proposed mechanisms often involve indirect modulation of neurotransmitter or immune signaling rather than a single defined target.
Selank is a synthetic heptapeptide developed in Russia. Its sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, a seven-residue chain built around the natural tetrapeptide tuftsin. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences first described the compound in the mid-1990s. The design combined the tuftsin core with an added Pro-Gly-Pro tail, a modification intended to extend the molecule's stability in biological fluids. Published work on the peptide has appeared mainly in Russian-language journals.
Reverse-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres is the standard purity method. Mass spectrometry, typically electrospray ionisation, confirms identity through the expected mass-to-charge pattern. Amino acid analysis can verify composition independently. Chiral purity requires separate techniques such as derivatisation followed by chromatographic separation, and such data are rarely reported for research-grade material.
Quantification in biological matrices relies on liquid chromatography coupled to tandem mass spectrometry with stable-isotope internal standards. Low plasma concentrations and adsorption to container surfaces both complicate measurement. Solid-phase extraction is often needed to reduce matrix interference before injection. Reported limits of quantification differ widely between laboratories, which makes direct comparison of pharmacokinetic results difficult and limits meta-analysis.
Peptide bonds are vulnerable to protease attack, and Selank is no exception. Measured half-life in serum is short, on the order of minutes in several reports, which explains why intranasal administration is the common route described in the literature. Absorption across the nasal mucosa partially bypasses first-pass hepatic metabolism. Quantitative data on human bioavailability remain limited and are difficult to compare across studies.
Cyproheptadine is a potent antihistamine or inverse agonist of the histamine H1 receptor. It also has anticholinergic, antiserotonergic, antidopaminergic, and local anesthetic activities. In one study, cyproheptadine had about the same affinity for the serotonin 5-HT2A and 5-HT2B receptors as for the histamine H1 receptor, about 8-fold selectivity for the histamine H1 receptor over the serotonin 5-HT2C receptor, about 2- to 8-fold selectivity for the H1 receptor over the muscarinic acetylcholine receptors, and about 4- to 52-fold selectivity for the histamine H1 receptor over the dopamine receptors. The drug shows lower affinity for α-adrenergic receptors and little to no affinity for the monoamine transporters. Of the serotonin receptors, it is an especially potent antagonist of the 5-HT2 receptors. This is thought to underlie its effectiveness in the treatment of serotonin syndrome. However, it is possible that blockade of 5-HT1 receptors may also contribute to its effectiveness in serotonin syndrome. Cyproheptadine has been reported to block 85% of 5-HT2 receptors in the human brain at a dose of 4 mg three times per day (12 mg/day total) and to block 95% of 5-HT2 receptors in the human brain at a dose of 6 mg three times per day (18 mg/day total) as measured with positron emission tomography (PET). The most widely used dose of cyproheptadine for serotonin syndrome has been said to be 4 mg, though doses of up to 16 mg have been used.
Around the time, an expert concludes that "AI art is everywhere right now", with even experts not knowing what it will mean, a news outlet establishes that "AI-generated art booms" and reports about issues of copyright and automation of professional artists, a news outlet investigates how online communities (e.g. their rules) confronted with many such artworks react, a news outlet raised concerns over deepfakes, a magazine highlights possibilities of enabling "new forms of artistic expression", an editorial notes that it may be seen as a welcome "augmentation of human capability". Moreover, additional functionalities – such as enabling the use of user-provided concepts (like an object or a style) learned from few images for novel personalized art generated from the associated word/s (2 Aug) or expanding beyond the borders of artistic images in the same style (31 Aug) – are reported. On 22 August, Stable Diffusion is released as free and open source software.
Sensory gating A process by which the brain filters out redundant or unnecessary stimuli from all the sensory inputs, often studied in schizophrenia research. Sensory map An organized representation of sensory information in the brain. For example, the somatotopic map in the primary somatosensory cortex. Serotonin A neurotransmitter involved in mood, sleep, appetite, and cognition. Dysregulation of serotonin systems is linked to depression and anxiety disorders. Short-term memory The capacity to hold a small amount of information in an active, readily accessible state for a short period of time. Often contrasted with long-term memory. Sleep spindle A burst of oscillatory brain activity visible on an EEG during Stage 2 non-REM sleep. Thought to play a role in memory consolidation. Somatic nervous system A component of the peripheral nervous system responsible for voluntary control of body movements via skeletal muscles. Somatosensory system The part of the sensory system concerned with the conscious perception of touch, pressure, pain, temperature, position, movement, and vibration. Spasticity A condition of increased muscle tone (hypertonia) and exaggerated reflexes, often resulting from damage to upper motor neurons. Spatial memory The part of memory responsible for recording information about one’s environment and spatial orientation. Heavily dependent on the hippocampus. Spike-timing-dependent plasticity (STDP) A form of synaptic plasticity in which the timing of neuronal spikes determines whether synapses are strengthened or weakened.
Crutzen (1933–2021), Dutch chemist, winner of the 1995 Nobel Prize in Chemistry for work on atmospheric chemistry, especially in relation to ozone Ana Maria Cuervo (born 1966), Spanish-American physician, researcher, and cell biologist, best known for work on autophagy Marie Curie (1867–1934), Polish and French radiation physicist, discovered the elements radium and polonium, 1903 Nobel Prize in Physics, 1911 Nobel Prize in Chemistry Pierre Curie (1859–1906), French physicist and chemist, 1903 Nobel Prize in Physics for work on radioactivity Robert Curl (1933–2022), American chemist, winner of 1996 Nobel Prize in Chemistry for discovery of the fullerene class of materials Theodor Curtius (1857–1928), German chemist known for the Curtius rearrangement, and also discovery of diazoacetic acid, hydrazine and hydrazoic acid Anthony Czarnik (born 1957), American chemist and inventor known for work on fluorescent chemosensors Emil Czyrniański (1824–1888), Polish chemist, known for developing chemical nomenclature in Polish
Sources: en.wikipedia.org
=== Business === Suga is also a founder of PeptiDream Inc. Tokyo, a publicly traded biopharmaceutical start-up company responsible for discovering and developing non-standard peptide therapeutics in addition to addressing unmet medical needs as well as investigating peptide drug conjugates (PDC), peptides, and small molecule-based drugs. It is traded publicly on the Tokyo First Stock Exchange Market (the market capitalization is over JY 600 billions), which has many partnerships with pharmaceutical companies in worldwide. Suga is chair of the editorial board at RSC Chemical Biology and associate editor at Angewandte Chemie.
integral membrane protein (IMP) Also intrinsic membrane protein. Any of a class of membrane proteins which are permanently embedded within or attached to the cell membrane (as opposed to those which are attached only temporarily). Integral membrane proteins can be subclassified into integral polytopic proteins, which span the entirety of the membrane, and integral monotopic proteins, which adhere only to one side.
== Nixon's visit to Moscow == At the time of the Easter Offensive, Kissinger was deeply involved in planning for Nixon's visit to Moscow in May 1972. The offensive brought to the fore the differences between Nixon and Kissinger. Nixon threatened to cancel his summit with Leonid Brezhnev in Moscow if the Soviet Union did not force North Vietnam to end the Easter Offensive at once, saying: "Whatever else happens, we cannot lose this war. The summit isn't worth a damn if the price for it is losing in Vietnam". Nixon, in his instructions to Kissinger, stated that he viewed the relations with the Soviet Union through the prism of the Vietnam War, and if the Soviets were not prepared to help, Kissinger "should just pack up and come home". Kissinger, for his part, believed that Nixon was massively exaggerating Soviet influence in North Vietnam and no longer believed, if he ever did, in Nixon's "linkage" concept. Kissinger feared that Nixon was obsessed with Vietnam, and damaging relations with the Soviet Union over Vietnam would destabilize the international power balance by increasing American-Soviet tensions. On 20 April 1972, Kissinger arrived in Moscow without informing the U.S. ambassador Jacob D. Beam, and then went to have tea with Brezhnev in the Kremlin. Nixon, as usual when under stress, departed for a marathon drinking session with Rebozo at Camp David, and via Haig kept sending messages to Kissinger urging him to be tough with Brezhnev.
Sources: en.wikipedia.org
Purity is usually reported as an HPLC area percentage, most often measured at 214 nm. Identity is confirmed separately by mass spectrometry. A certificate of analysis should state both the method and the observed value.
Dry powder is kept frozen, desiccated, and shielded from light. Dissolved material is aliquoted and frozen to limit freeze-thaw cycles. Short-term refrigerated storage is common for working solutions.
Russia registers it as a prescription nasal product. Most other markets classify it as a research chemical with no approved medical use. Oversight of purity and labeling is consequently minimal in those markets.
Reports describe effects on GABA-A receptor expression, monoamine turnover, and neurotrophic factor levels. These are proposed mechanisms drawn mainly from animal models. No single molecular target has been established.